ConceptioArchiveOKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORYmetadata only

First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results

Takahashi, Yuko et al.
OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY · Papers
Open Source ↗Direct PDF ↓
selective estrogen receptor degrader (serd), aromatase inhibitor (ai), endocrine therapy (et), hormone receptor-positive (hr+), advanced breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 1001662
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.